コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ificant differences in the severity of other abdominal symptoms.
2 ccumulate intra-abdominal fat that may cause abdominal symptoms.
3 In July, 1995, the patient had recurrent abdominal symptoms.
4 ine percent of 521 HAE attacks only involved abdominal symptoms.
5 high prevalance of long-lasting fatigue and abdominal symptoms.
7 e from baseline in daily bowel habits, daily abdominal symptoms, and weekly global assessments, in ad
9 ght upper quadrant symptoms, (b) generalized abdominal symptoms, (c) unexplained sepsis, or (d) sepsi
11 sparaginase-associated pancreatitis, risk of abdominal symptoms dropped from 8% (26 of 312) to 0% (0
12 atients who had been using indinavir without abdominal symptoms for at least 6 months and ten HIV-1-i
13 d and sustained improvement of bowel habits, abdominal symptoms, global relief, and quality of life i
14 ed with selective liver enlargement and that abdominal symptoms in ADPKD patients may be because of e
15 linaclotide significantly reduced bowel and abdominal symptoms in patients with chronic constipation
17 s variable and most patients presenting with abdominal symptoms in primary care will not have celiac
18 Fifteen patients presenting with unspecific abdominal symptoms in which food allergy was detected in
19 of linaclotide significantly improved other abdominal symptoms, including discomfort and bloating, a
20 D), a common disorder characterized by upper abdominal symptoms, including discomfort or postprandial
21 ctal bleeding (OR, 0.28; 95% CI, 0.20-0.40), abdominal symptoms (OR, 0.15; 95% CI, 0.10-0.21), or oth
22 register of Sweden, were given the validated Abdominal Symptom Questionnaire 1998-2001; 1000 of these
23 sophagogastroduodenoscopy and were given the Abdominal Symptom Questionnaire along with the Hospital
24 gn, enrolled adults presenting with nonacute abdominal symptoms, the prevalence of celiac disease was
25 in ten HIV-1-positive patients who had such abdominal symptoms to measure total adipose tissue (TAT)
29 ydrate malabsorption), flatus frequency, and abdominal symptoms were assessed after subjects ingested
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。